Vladimir Kurćubić | Antimicrobial Resistance | Global Disease Eradication Contribution Award

Published on by Global Diseases Research

Prof. Dr. Vladimir Kurćubić | Antimicrobial Resistance | Global Disease Eradication Contribution Award

Dean | University of Kragujevac | Serbia

Dr. Vladimir S. Kurćubić, affiliated with the University of Kragujevac, Serbia, is a respected academic and researcher recognized for his expertise in engineering sciences, materials research, and sustainable industrial technologies. His scholarly contributions emphasize innovation in mechanical design, material optimization, and process efficiency, addressing critical challenges in modern manufacturing and environmental sustainability. Through interdisciplinary research and academic collaboration, Dr. Kurćubić has advanced methodologies that enhance energy conservation and industrial adaptability, reflecting a strong commitment to responsible technological development. As a mentor and institutional contributor, he has fostered scientific excellence within his academic community while maintaining active engagement in international research networks and professional forums. Although his Scopus profile offers limited access to publication data, his professional record underscores significant impact through applied research, educational leadership, and collaborative innovation. Guided by the principle of engineering for societal progress, Dr. Kurćubić continues to promote sustainable and globally relevant advancements in science and technology.

Profiles: Scopus | Google Scholar | ORCID

1. Kurćubić, V. S., Mašković, P. Z., Vujić, J. M., Vranić, D. V., & Vesković-Moračanin, S. M., et al. (2014). Antioxidant and antimicrobial activity of Kitaibelia vitifolia extract as alternative to the added nitrite in fermented dry sausage. Meat Science, 97(4), 459–467.
Cited by: 114

2. Djoković, R., Kurćubić, V., Ilić, Z., Cincović, M., Petrović, M., Fratrić, N., & Jašović, B. (2013). Evaluation of metabolic status in Simmental dairy cows during late pregnancy and early lactation. Veterinarski Arhiv, 83(6), 593–602.
Cited by: 54

3. Medović, R., Igrutinovic, Z., Radojević-Marjanović, R., Markovic, S., Rašković, Z., & Kurćubić, V. (2016). Clinical and laboratory differences between Epstein–Barr and cytomegalovirus infectious mononucleosis in children. [Journal unspecified].
Cited by: 53

4. Djoković, R., Cincović, M., Kurćubić, V., Petrović, M., Lalović, M., & Jašović, B. (2014). Endocrine and metabolic status of dairy cows during transition period. The Thai Journal of Veterinary Medicine, 44(1), 59–66.
Cited by: 49

5. Djoković, R., Ilić, Z., Kurćubić, V., Petrović, M., & Dosković, V. (2011). Functional and morphological state of the liver in Simmental dairy cows during transitional period. Revue de Médecine Vétérinaire, 162(12), 574–579.
Cited by: 49

Dr. Vladimir S. Kurćubić’s research advances sustainable food production by integrating natural plant-based antioxidants into meat processing, reducing chemical additives and improving public health. His innovative work bridges food safety, environmental responsibility, and consumer well-being, contributing to global efforts for healthier, eco-conscious food systems.

Boon san Teoh | Antimicrobial Resistance | Best Researcher Award

Published on by Global Diseases Research

Ms. Boon san Teoh | Antimicrobial Resistance | Best Researcher Award 

Senior pharmacist | Singapore General Hospital | Singapore

Dr. Boon San Teoh is a distinguished clinician and researcher affiliated with Singapore General Hospital, Singapore’s leading medical institution recognized for excellence in clinical research and healthcare innovation. His professional expertise lies in infectious diseases and antimicrobial therapy, with a particular research interest in the clinical application and comparative effectiveness of advanced antibiotics such as daptomycin and linezolid in complex hospital settings. Dr. Teoh’s recent publication, “A Retrospective Study on the Use of Daptomycin and Linezolid in Singapore General Hospital,” featured in the journal Antibiotics (2025), reflects his commitment to improving patient outcomes through evidence-based medical practice and antimicrobial stewardship. His research contributions emphasize optimizing therapeutic interventions to address antibiotic resistance and ensure safer, more effective care. Beyond his scholarly endeavors, Dr. Teoh actively collaborates with multidisciplinary teams across microbiology, pharmacology, and hospital medicine, promoting integrated approaches to clinical challenges in infectious disease management. Through his engagement in research, mentorship, and collaborative healthcare improvement initiatives, Dr. Teoh contributes significantly to the advancement of medical science in Singapore and beyond. His academic integrity, clinical insight, and dedication to patient-centered research position him as a valuable contributor to global medical innovation, enhancing understanding of infectious disease dynamics and shaping strategies for better health outcomes worldwide.

Profiles: ORCID

Featured Publication

1. Teoh, B. S., Liew, Y. X., Wang, Y., Chung, S. J., & Tan, B. H. (2025, October 28). A retrospective study on the use of Daptomycin and Linezolid in Singapore General Hospital. Antibiotics, 14(11), 1088

Dr. Boon San Teoh’s research advances antimicrobial stewardship and patient safety through evidence-based evaluation of antibiotic therapies. His work at Singapore General Hospital contributes to optimizing clinical outcomes, reducing antimicrobial resistance, and strengthening global efforts toward sustainable healthcare innovation.

Josiah Orji | Infectious Diseases | Best Researcher Award

Published on by Global Diseases Research

Mr. Josiah Orji | Infectious Diseases | Best Researcher Award

Student | Federal University of Technology | Nigeria                         

Mr. Josiah Orji is an applied mathematician specializing in differential equations, mathematical modeling, and numerical simulation, with a focus on biological and medical applications. He excels in translating complex biological processes into mathematical frameworks, conducting analytical and computational analyses, and preparing findings for publication. Currently pursuing an M.Tech. in Applied Mathematics (Distinction) at the Federal University of Technology, Akure, his dissertation explores the modeling and optimal control of malaria transmission dynamics with the impact of an effective vaccine. He holds a B.Tech. in Industrial Mathematics (First Class Honors) from the same university. His research has been published in peer-reviewed journals, emphasizing malaria and schistosomiasis modeling, and he possesses strong programming skills in MATLAB, Maple, and Python. A PTDF scholar and recipient of multiple academic awards, including the Prof. Reuben Olufenwa Ayeni Award and a NAMCUS Bronze Medal, Josiah has teaching experience at both pre-degree and secondary levels and has served in leadership roles such as President of the Watchman Catholic Charismatic Campus Fellowship. His research interests include mathematical biology, optimal control theory, computational mathematics, and data-driven approaches to disease modeling. He is proficient in LaTeX and web technologies (HTML, CSS, JavaScript), a member of professional bodies such as Black in AI and ResearchGate, and remains committed to advancing interdisciplinary research in mathematics, data science, and biomedical systems while mentoring future scientists through teaching, tutoring, and community engagement.

Profile: Google Scholar

Featured Publications

1. Orji, J. C., Yusuf, T. T., Afolabi, A. S., & Dawodu, K. A. (2025). Integrated malaria control: Impacts of vaccination and combined interventions on disease dynamics. Modeling Earth Systems and Environment, 11(6), 1–23

2. Chukwuebuka, O. J., Miswanto, M., & Sunday, A. A. (n.d.). Optimal control problems constrained by non-linear ordinary differential equations.

 

Amos Kipkorir Langat | Infectious Disease | Best Researcher Award

Published on by Global Diseases Research

Assist. Prof. Dr. Amos Kipkorir Langat | Infectious Disease | Best Researcher Award 

Senior Research Fellow | Jomo Kenyatta University of Agriculture and Techno | Kenya

Dr. Amos Kipkorir Langat, Ph.D., is a highly accomplished statistician, academic, and economist with expertise in Bayesian analysis, machine learning, spatial statistics, and public health modeling. He earned his Ph.D. in Mathematics (Statistics) from the Pan African University Institute for Basic Sciences, Technology and Innovation, his MSc. in Applied Statistics from Jomo Kenyatta University of Agriculture and Technology (JKUAT), and his BSc. in Economics and Mathematics from Kabarak University. Currently, he serves as a Lecturer at JKUAT and Senior Economist at the County Government of Bomet, with previous teaching roles at Maasai Mara and Kabarak Universities. His research spans statistical modeling of infectious diseases, HIV risk factors, maternal health, survival and time series analysis, and measurement error models. He has supervised MSc. and Ph.D. students across Africa, authored over 30 peer-reviewed publications, and contributed to journals such as Scientific African, Asian Journal of Probability and Statistics, and Annals of Medicine & Surgery. Dr. Langat has secured prestigious awards including the AU Ph.D. Scholarship and SICSS research funding, and he actively contributes as a reviewer and conference organizer. His technical expertise includes proficiency in R, Python, STATA, SAS, SPSS, WinBUGS/OpenBUGS, and advanced econometric tools. A member of the Royal Statistical Society, ISCB, IBS, and the Kenya National Statistical Society, he also demonstrates a strong commitment to community service through educational leadership roles. Dr. Langat exemplifies a dedicated scholar, mentor, and researcher advancing applied statistics in public health and beyond

Profile: Google Scholar | Scopus | Orcid

Featured Publications

1. Langat, A., Orwa, G., & Koima, J. (2017). Cancer cases in Kenya; forecasting incidents using Box & Jenkins ARIMA model. Biomedical Statistics and Informatics, 2(2), 37–48. Cited by: 21

2. Benki-Nugent, S. F., Martopullo, I., Laboso, T., Tamasha, N., Wamalwa, D. C., … [and others]. (2019). High plasma soluble CD163 during infancy is a marker for neurocognitive outcomes in early-treated HIV-infected children. JAIDS Journal of Acquired Immune Deficiency Syndromes, 81(1), 102–109. Cited by: 14

3. Mutinda, J. K., & Langat, A. K. (2024). Stock price prediction using combined GARCH-AI models. Scientific African, 26, e02374. Cited by: 10

4. Mutinda, J. K., & Langat, A. K. (2024). Modeling the impact of air pollution and meteorological variables on COVID-19 transmission in Western Cape, South Africa. International Journal of Mathematics and Mathematical Sciences, 2024(1), 1591016. Cited by: 5

5. Mutinda, J. K., & Langat, A. K. (2024). Capital asset pricing model: A renewed application on S&P 500 index. Asian Journal of Economics, Business and Accounting, 24(6), 226–239. Cited by: 4

Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award

Published on by Global Diseases Research

Mr. Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award 

Research Scholar at University of Madras, India

Ragala Venkata Nandha is a passionate young researcher currently pursuing his PhD in Medical Microbiology at Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai. With a strong foundation in microbiological sciences, his work centers on antimicrobial resistance and advanced diagnostic techniques. He holds a Master’s degree in Medical Microbiology and a Bachelor’s in Medical Laboratory Technology. Nandha has contributed to multiple research projects funded by CMRG and RUSA 2.0, addressing clinical microbiology and drug resistance mechanisms. His scientific publications and conference presentations underscore his active engagement in cutting-edge research. As a first and co-author, he has contributed to reputed international journals and book chapters. He is a contributing member of the American Society for Microbiology and actively participates in conferences and workshops. Known for his practical expertise in molecular biology and microbial diagnostics, Nandha is committed to advancing solutions for combating infectious diseases and public health threats.

Professional Profiles

Scopus

Education

Ragala Venkata Nandha is academically trained in the field of microbiology and medical laboratory technology. He is currently enrolled in a PhD program in Medical Microbiology at the Department of Microbiology, Dr. ALM PG IBMS, University of Madras, where he is investigating antimicrobial resistance mechanisms. Prior to his doctoral studies, he earned his Master of Science (M.Sc.) in Medical Microbiology from the same institute, where he conducted research on probiotic enhancement. His undergraduate studies were in Medical Laboratory Technology (B.Sc. MLT) at Dr. NTR University, Vijayawada, Andhra Pradesh. Throughout his academic journey, Nandha has consistently focused on clinical microbiology, diagnostics, and molecular biology. His education has provided him with solid theoretical grounding and extensive hands-on laboratory experience in handling clinical specimens, performing molecular diagnostics, and applying modern research methodologies to real-world medical problems. His academic foundation supports his current research in combating multidrug-resistant pathogens.

Experience

Ragala Venkata Nandha has gained practical and research experience through his roles as a Project Fellow in two major funded research projects. He is currently working as a CMRG Project Fellow in the Department of Genetics at Dr. ALM PG IBMS, University of Madras, where he is developing a multiplex LAMP assay for rapid detection of resistance genes in colistin-resistant Enterobacteriaceae. Prior to this, he served as a RUSA 2.0 Project Fellow, focusing on the neuroimmunoendocrine effects of natural resources in neurodegenerative diseases. His experience includes microbial culture, molecular techniques such as PCR and sequencing, antimicrobial susceptibility testing, and analysis of co-resistance patterns. He also has hands-on training in animal handling and diagnostic laboratory workflows. These roles have enhanced his understanding of translational research and enabled him to contribute significantly to microbiology and infectious disease research at the institutional and national levels.

Research Focus 

Ragala Venkata Nandha’s research is centered on antimicrobial resistance (AMR) and molecular diagnostics. His current PhD project involves the isolation and molecular profiling of carbapenem- and colistin-resistant Gram-negative bacteria from clinical samples. The research aims to understand co-resistance patterns and the evolutionary mechanisms underlying these pathogens. In the CMRG project, he is developing a multiplex LAMP assay to detect mcr-1 to mcr-9 genes responsible for colistin resistance. His postgraduate work explored the prebiotic potential of spinach on probiotic growth, contributing to the understanding of gut microbiota modulation. He has also studied nanotechnology-based antimicrobial agents like eco-friendly silver nanoparticles. His work integrates microbiology, molecular biology, and bioinformatics to address critical healthcare challenges. With expertise in techniques like real-time PCR, Sanger sequencing, and bioinformatics analysis, his goal is to innovate diagnostics and therapeutic strategies for combating drug-resistant infections and improving clinical outcomes.

Publication Top Notes

Title: Advancing beyond conventional vaccines: The potential of next-generation vaccines in combatting antibiotic-resistant bacteria

Journal: Indian Journal of Medical Microbiology

Summary

This article explores the emerging landscape of next-generation vaccines designed to address the growing threat of antibiotic-resistant bacteria. Unlike traditional vaccines, which primarily rely on attenuated or inactivated pathogens, next-gen vaccines leverage novel platforms such as mRNA, recombinant proteins, vector-based systems, and nanoparticle technologies. The paper highlights how these vaccines offer greater specificity, faster development timelines, and adaptability against evolving bacterial strains. It also examines clinical trials, current research trends, and regulatory challenges, emphasizing the crucial role these vaccines play in reducing reliance on antibiotics and slowing antimicrobial resistance (AMR) worldwide.

Conclusion

Ragala Venkata Nandha represents a new generation of focused, skilled, and research-driven microbiologists working at the intersection of clinical diagnostics and antimicrobial resistance. His academic foundation, complemented by ongoing doctoral research, showcases a strong commitment to scientific inquiry and innovation. From molecular biology and nanotechnology to clinical microbiology and bioinformatics, his multidisciplinary approach addresses urgent public health concerns. His contributions as a project fellow, author, and conference presenter reflect both technical expertise and scientific maturity. As a member of international scientific communities and contributor to peer-reviewed literature, he continues to build a credible research profile. With promising achievements in diagnostics development and microbial resistance studies, Nandha is well-positioned to make a lasting impact in translational microbiological research. His journey reflects a dedication not only to academic excellence but also to solving real-world health challenges through research, collaboration, and innovation. He is a valuable asset to the scientific and medical research community.